ArticleAnalytical and bioanalytical chemistry2026
Development of 3D printed capillaric circuit interfacing with silver nanoparticle embedded membrane for simultaneous analysis of duplex samples via fluorescence sandwich immunoassays.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capillaric microfluidic circuits provide the capability to miniaturize immunoassays, reduce assay time, and perform precise liquid handling without the need for external equipment. While capillaric circuits have been well studied and have often been combined with paper substrates, most circuits require complex fabrication processes and are limited to the analysis of a single sample. In this work, we evaluated the effects of surface treatment on capillary flow, controlled sample volume through altering the number of reservoirs used for sample delivery, evaluated the effects of inkjet microarray printing on various immunoassay formats, and enabled the simultaneous detection of duplex samples within a single device using fluorescence sandwich immunoassays. We demonstrated that plasma treatment provides inconsistency in fluid flow compared to untreated circuits that use Tween-20 additive in reagents for flow control. Furthermore, due to the stress that molecules undergo during inkjet microarray printing, sandwich immunoassays exhibited resilience and reliability compared to reverse-phase immunoassays. In this work, we controlled sample volume through utilizing multiple channels to deliver sample to the circuit, offering flexibility based on sample availability. Using a silver nanoparticle embedded membrane to provide metal enhanced fluorescence, we enabled the simultaneous detection of the EGFR protein from two samples with a unique 2-sample circuit design, offering detection limits of 0.98 ng/mL in PBS-T and 0.13 ng/mL in spiked normal human plasma within 1 h. This technology offers potential scalability of capillaric circuits for the automation of bioassays for various samples with reduced time and cost, suitable for rapid disease diagnostics.
Indexed as
Identifiers
42362793What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.